AVILAR THERAPEUTICS
Avilar Therapeutics is a biopharmaceutical company focusing on the discovery and development of extracellular protein degraders, a new frontier in targeted protein degradation.
AVILAR THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2020-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.avilar-tx.com
Total Employee:
11+
Status:
Active
Total Funding:
75 M USD
Technology used in webpage:
Google Maps Google Google Cloud
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Autolus
Autolus is a biopharmaceutical company focused on T-cell programming and manufacturing technology.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
TCR2
TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuC™ platform.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Current Advisors List
Current Employees Featured
Founder
Investors List
Medical Excellence Capital
Medical Excellence Capital investment in Seed Round - Avilar Therapeutics
Astellas Venture Management
Astellas Venture Management investment in Seed Round - Avilar Therapeutics
Sanofi Ventures
Sanofi Ventures investment in Seed Round - Avilar Therapeutics
RA Capital Management
RA Capital Management investment in Seed Round - Avilar Therapeutics
RA Capital Management
RA Capital Management investment in Seed Round - Avilar Therapeutics
Key Employee Changes
Date | New article |
---|---|
2022-06-15 | Avilar Therapeutics Appoints Adam Muzikant, PhD, as Chief Business Officer |
Official Site Inspections
http://www.avilar-tx.com Semrush global rank: 7.36 M Semrush visits lastest month: 804
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Avilar Therapeutics"
About Us - Avilar Therapeutics
At Avilar, we are moving beyond the boundaries of the cell to pioneer the discovery and development of extracellular protein degraders.See details»
Team - Avilar Therapeutics
Rene Lemieux, PhD SVP and Head of Drug Discovery SciencesSee details»
Avilar Therapeutics - LinkedIn
Avilar Therapeutics is a biopharmaceutical company pioneering the discovery and development of extracellular protein degraders, a new frontier in targeted protein degradation.See details»
Avilar Therapeutics - Crunchbase Company Profile
Avilar Therapeutics is a biopharmaceutical company focusing on the discovery and development of extracellular protein degraders, a new frontier in targeted …See details»
Avilar Therapeutics 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Avilar Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Avilar Therapeutics Org Chart + Executive Team - The Official Board
The org chart of Avilar Therapeutics contains its 18 main executives including Daniel Gau, Effie Tozzo and Paul Muir.See details»
Avilar Therapeutics, Inc. (Avilar Therapeutics, Inc.) - 药物管线_专利_ …
Avilar has built a proprietary discovery platform that includes novel, high-affinity, small molecule ASGPR (asialoglycoprotein receptor) ligands and advanced modeling of the biophysics, …See details»
Avilar Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Avilar Therapeutics, Inc. of Newton, MA. Get the latest business insights from Dun & Bradstreet.See details»
Avilar Therapeutics Increases Financing to $75 Million to Advance ...
In addition, the funding will be used to grow the company and expand the Avilar platform of proprietary technologies, all custom-built and tailored to designing and building extracellular …See details»
Avilar Therapeutics - VentureRadar
"Avilar Therapeutics is a biotech company developing ATACs (ASGPR Targeting Chimeras), a novel class of degrader designed to harness a natural endogenous process for protein …See details»
Avilar Therapeutics Increases Financing to $75 Million to Advance ...
Feb 16, 2023 Avilar Therapeutics, a biopharmaceutical company focused on extracellular protein degradation, today announced it has raised additional funding with an expanded syndicate of …See details»
Avilar - Products, Competitors, Financials, Employees, …
About Avilar Avilar Therapeutics is a biopharmaceutical company focused on the discovery and development of novel protein degraders within the healthcare sector. The company's main …See details»
Avilar Therapeutics - LifeScienceHistory.com
Avilar Therapeutics is a biopharmaceutical company pioneering the discovery and development of extracellular protein degraders, a new frontier in targeted protein degradation.See details»
About - Avilar Therapeutics
© 2025 Avilar Therapeutics, Inc.PrivacySee details»
Avilar Therapeutics
Avilar Therapeutics is developing methods to degrade extracellular proteins. More than 35% of human proteins are located outside the cell and many have a clearly defined role in the …See details»
Avilar - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 28, 2025 Avilar is a seed company based in Waltham (United States), founded in 2020 by Milind Deshpande and James Kasuboski. It operates as a Provider of drug discovery platform …See details»
Avilar Therapeutics Increases Financing to $75 Million to Advance ...
Feb 16, 2023 Avilar is leveraging its ATAC platform to create a broad and diverse pipeline of first-in-class extracellular protein degraders. Avilar is based in Waltham, MA.See details»
Avilar Competency Model | Avilar Competency Management
The Avilar Competency Model was developed from decades of work with organizations of all types and sizes. It contains over 350 skills clustered into more than 50 skill groups. Our …See details»
Core Values - Avilar Therapeutics
Everyone at Avilar has the audacity to believe that by radically and rapidly innovating together we will fundamentally transform the lives of patients.See details»